Stericycle Inc (NASDAQ:SRCL) Shares Sold by Thompson Siegel & Walmsley LLC

Thompson Siegel & Walmsley LLC lowered its position in shares of Stericycle Inc (NASDAQ:SRCL) by 39.7% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 935,879 shares of the business services provider’s stock after selling 615,558 shares during the quarter. Thompson Siegel & Walmsley LLC owned 1.03% of Stericycle worth $50,931,000 as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. JOYN Advisors Inc. boosted its stake in shares of Stericycle by 1,253.7% during the fourth quarter. JOYN Advisors Inc. now owns 731 shares of the business services provider’s stock valued at $27,000 after purchasing an additional 677 shares during the period. Bronfman E.L. Rothschild L.P. increased its holdings in shares of Stericycle by 159.5% during the fourth quarter. Bronfman E.L. Rothschild L.P. now owns 807 shares of the business services provider’s stock valued at $30,000 after acquiring an additional 496 shares in the last quarter. Pearl River Capital LLC acquired a new position in shares of Stericycle during the fourth quarter valued at about $41,000. Blue Sky Asset Management LLC acquired a new position in shares of Stericycle during the first quarter valued at about $60,000. Finally, Quadrant Capital Group LLC increased its holdings in shares of Stericycle by 1,186.8% during the first quarter. Quadrant Capital Group LLC now owns 1,171 shares of the business services provider’s stock valued at $61,000 after acquiring an additional 1,080 shares in the last quarter. 96.52% of the stock is currently owned by institutional investors and hedge funds.

SRCL has been the topic of several research reports. BidaskClub downgraded shares of Stericycle from a “buy” rating to a “hold” rating in a report on Wednesday, May 8th. ValuEngine lowered Stericycle from a “hold” rating to a “sell” rating in a research report on Monday, April 1st. Zacks Investment Research upgraded Stericycle from a “sell” rating to a “hold” rating in a research report on Wednesday, May 1st. TheStreet lowered Stericycle from a “c-” rating to a “d” rating in a research report on Wednesday, March 20th. Finally, Robert W. Baird lowered Stericycle from a “neutral” rating to an “underperform” rating and set a $44.00 target price on the stock. in a research report on Wednesday, April 17th. Five equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and three have issued a buy rating to the company’s stock. Stericycle has a consensus rating of “Hold” and a consensus target price of $59.00.

In related news, Director Mark C. Miller sold 260,314 shares of the business’s stock in a transaction that occurred on Tuesday, April 9th. The stock was sold at an average price of $57.18, for a total transaction of $14,884,754.52. Following the completion of the sale, the director now owns 325,848 shares in the company, valued at $18,631,988.64. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Company insiders own 2.30% of the company’s stock.

Shares of NASDAQ:SRCL traded down $0.01 during midday trading on Friday, reaching $47.75. 762,316 shares of the company’s stock were exchanged, compared to its average volume of 1,070,257. The stock has a 50 day moving average price of $46.91. Stericycle Inc has a fifty-two week low of $34.36 and a fifty-two week high of $71.43. The company has a market capitalization of $4.26 billion, a PE ratio of 10.73, a price-to-earnings-growth ratio of 1.84 and a beta of 1.24. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 1.17.

Stericycle (NASDAQ:SRCL) last announced its earnings results on Thursday, May 2nd. The business services provider reported $0.57 EPS for the quarter, missing analysts’ consensus estimates of $0.87 by ($0.30). Stericycle had a negative net margin of 8.92% and a positive return on equity of 12.56%. The firm had revenue of $830.10 million for the quarter, compared to analysts’ expectations of $866.19 million. During the same quarter last year, the business earned $1.21 earnings per share. The business’s revenue was down 7.3% compared to the same quarter last year. On average, analysts expect that Stericycle Inc will post 3.31 EPS for the current year.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It operates through three segments: Domestic and Canada Regulated Waste and Compliance; International Regulated Waste and Compliance; and Domestic Communication and Related Services.

Recommended Story: Tariff

Institutional Ownership by Quarter for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.